Skip to main content

RVL Pharmaceuticals plc

RVLPDelisted Nov 20, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001739426

RVL Pharmaceuticals plc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Oct 23, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $1.57M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding RVL Pharmaceuticals plc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of RVLP: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders3846+8
Shares16.4M24.0M+7.68M (+46.9%)
Value$22.2M$50.5M+$28.3M (+127.4%)

New holders (15)

Institutions that held RVL Pharmaceuticals plc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to RVLP in Q3 2022
InstitutionSharesValue% of portfolio
UBS Oconnor LLC276,428$580.0K0.01%
Worth Venture Partners, LLC185,647$390.0K0.24%
Raymond James Financial Services Advisors, Inc.29,519$62.0K0.00%
Virtu Financial LLC22,835$48.0K0.00%
Citadel Advisors LLC21,561$46.0K0.00%
IPG Investment Advisors LLC17,500$36.8K0.01%
Two Sigma Securities, LLC16,298$34.0K0.00%
Tower Research Capital LLC (TRC)15,483$32.0K0.00%
Susquehanna International Group, LLP14,663$31.0K0.00%
Marshall Wace, LLP11,300$24.0K0.00%
Ergoteles LLC10,927$23.0K0.00%
Citigroup Inc8,356$18.0K0.00%
Barclays PLC2,849$6.00K0.00%
IFP Advisors, Inc306$2.00K0.00%
Tilia Fiduciary Partners, Inc.435$1.00K0.00%

Sold out (7)

Institutions that held RVL Pharmaceuticals plc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of RVLP in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Prudential Financial Inc25,000$34.0K
Two Sigma Investments, LP22,413$30.0K
Engineers Gate Manager LP21,870$30.0K
Group One Trading, L.P.2,000$3.00K
Simplex Trading, LLC1,598$2.00K
The PNC Financial Services Group, Inc.700$1.00K
Allworth Financial LP75$0